Cargando…

Conversation about Serostatus decreases risk of acquiring HIV: results from a case control study comparing MSM with recent HIV infection and HIV negative controls

BACKGROUND: Data on knowledge, attitudes, behaviour and practices (KABP) of persons with recent HIV infection compared to controls with negative HIV test result provide information on current risk patterns and can help to re-focus HIV prevention strategies. METHODS: From March 2008 through May 2010,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos-Hövener, Claudia, Zimmermann, Ruth, Kücherer, Claudia, Bätzing-Feigenbaum, Jörg, Wildner, Stephan, Hamouda, Osamah, Marcus, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046506/ https://www.ncbi.nlm.nih.gov/pubmed/24885694 http://dx.doi.org/10.1186/1471-2458-14-453

Ejemplares similares

Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014
por: Hofmann, Alexandra, et al.
Publicado: (2017)

The denominator problem: Estimating MSM-specific incidence of sexually transmitted infections and prevalence of HIV using population sizes of MSM derived from Internet surveys
por: Marcus, Ulrich, et al.
Publicado: (2009)

First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study
por: zu Knyphausen, Fabia, et al.
Publicado: (2014)

A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling
por: Zimmermann, Ruth, et al.
Publicado: (2014)

HIV serostatus knowledge and serostatus disclosure with the most recent anal intercourse partner in a European MSM sample recruited in 13 cities: results from the Sialon-II study
por: Marcus, Ulrich, et al.
Publicado: (2017)

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
por: Machnowska, Patrycja, et al.
Publicado: (2019)

High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011–14)
por: Wenz, Benjamin, et al.
Publicado: (2016)

The impact of an unknown HIV serostatus on inpatient mortality
por: Moodley, Yoshan
Publicado: (2017)

The importance of serostatus awareness in arresting the spread of HIV
por: Mayer, Kenneth H, et al.
Publicado: (2018)

Estimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany
por: Schmidt, Daniel, et al.
Publicado: (2014)

Analysis of transmitted drug resistance and HIV-1 subtypes using dried serum spots of recently HIV-infected individuals in 2013 in Germany
por: Andrea, Hauser, et al.
Publicado: (2014)

HIV serostatus disclosure is not associated with safer sexual behavior among HIV-positive men who have sex with men (MSM) and their partners at risk for infection in Bangkok, Thailand
por: Edwards-Jackson, Nneka, et al.
Publicado: (2012)

CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
por: Oh, Djin-Ye, et al.
Publicado: (2008)

HIV serostatus disclosure among people living with HIV/AIDS in Mwanza, Tanzania
por: Yonah, Gladys, et al.
Publicado: (2014)

Gut-dependent inflammation and alterations of the intestinal microbiota in individuals with perinatal HIV exposure and different HIV serostatus
por: Tincati, Camilla, et al.
Publicado: (2022)

Association of HIV Serostatus and Inflammation With Ascending Aortic Size
por: Minhas, Anum S., et al.
Publicado: (2022)

Dynamics of the HIV Epidemic in MSM
por: Jia, Yujiang, et al.
Publicado: (2014)

The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort
por: Altmann, Mathias, et al.
Publicado: (2012)

Comparison of different strategies for controlling HIV/AIDS spreading in MSM
por: Lou, Jie, et al.
Publicado: (2018)

Disclosure of HIV serostatus and condomless sex among men living with HIV/AIDS in Florida
por: Cook, Christa L., et al.
Publicado: (2018)

Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors
por: Meixenberger, Karolin, et al.
Publicado: (2017)

Associations between QT interval subcomponents, HIV serostatus, and inflammation
por: Wu, Katherine C., et al.
Publicado: (2019)

Predictors of HIV serostatus disclosure to partners among HIV-positive pregnant women in Morogoro, Tanzania
por: Kiula, Elizabeth S, et al.
Publicado: (2013)

High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany
por: Jansen, Klaus, et al.
Publicado: (2015)

HIV serostatus disclosure: Experiences and perceptions of people living with HIV/AIDS and their service providers in Gujarat, India
por: Patel, Sangita V., et al.
Publicado: (2012)

HIV serostatus disclosure in the treatment cascade: evidence from Northern Tanzania
por: Ostermann, Jan, et al.
Publicado: (2015)

Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus
por: Ross, Ryan D., et al.
Publicado: (2020)

Safer disclosure of HIV serostatus for women living with HIV who experience or fear violence: a systematic review
por: Kennedy, Caitlin E, et al.
Publicado: (2015)

Barriers to and facilitators of HIV serostatus disclosure to sexual partners among postpartum women living with HIV in South Africa
por: Adeniyi, Oladele Vincent, et al.
Publicado: (2021)

Non-Disclosure of HIV-Positive Serostatus: Unmatched Case–Control Study in People Living with HIV in Public Health Facilities of Gedeo Zone, Southern Ethiopia
por: Tessema, Betelhem Tadesse, et al.
Publicado: (2023)

Prevalence and correlates of carotid plaque in a mixed HIV-serostatus cohort in Uganda
por: Bibangambah, Prossy, et al.
Publicado: (2021)

Telling Children with Perinatal HIV About Their HIV Serostatus: Healthcare Workers’ Practices and Barriers to Disclosing in a South African Rural Health District
por: Madiba, Sphiwe, et al.
Publicado: (2021)

The role of internalised HIV stigma in disclosure of maternal HIV serostatus to children perinatally HIV‐exposed but uninfected: a prospective study in the United States
por: Davtyan, Mariam, et al.
Publicado: (2023)

HIV Serostatus Disclosure and Its Predictors Among Children Living With HIV in Ethiopia: A Systematic Review and Meta-Analysis
por: Lemma, Tesfanesh, et al.
Publicado: (2022)

Understanding the HIV Epidemic Among MSM in Baltimore: A Modeling Study Estimating the Impact of Past HIV Interventions and Who Acquired and Contributed to Infections
por: Silhol, Romain, et al.
Publicado: (2020)

Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM
por: Estcourt, Claudia, et al.
Publicado: (2021)

HIV testing in nonhealthcare facilities among adolescent MSM
por: Marano, Mariette R., et al.
Publicado: (2017)

Rethinking MSM, Trans* and Other Categories in HIV Prevention
por: Bromberg, Daniel J.
Publicado: (2020)

Asian countries urged to address HIV/AIDS in MSM
por: Cheng, Margaret Harris
Publicado: (2009)

Elimination of HIV transmission in Japanese MSM with combination interventions
por: Wang, Yijing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m11r3u2s8qe4lkjibuh1j1751n